Related Experiment Video
Updated: Feb 25, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.5K
Melt-Cast Noninvasive Ocular Inserts for Posterior Segment Drug Delivery
Sai Prachetan Balguri1, Goutham R Adelli1, Akshaya Tatke1
1Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi 38677.
Journal of Pharmaceutical Sciences
|August 6, 2017
Summary
Melt-cast ocular inserts effectively delivered drugs with varying properties. These novel inserts significantly enhanced drug permeation and ocular tissue distribution compared to traditional solutions.
Area of Science:
- Ophthalmology
- Pharmaceutics
- Materials Science
Background:
- Ocular drug delivery faces challenges due to the eye's biological barriers.
- Developing effective topical ocular drug delivery systems is crucial for treating eye diseases.
Purpose of the Study:
- To evaluate melt-cast ocular inserts for delivering drugs with diverse physicochemical properties.
- To assess the utility of polyethylene oxide N10 as a matrix for ophthalmic inserts.
Main Methods:
- Fabrication of melt-cast ophthalmic inserts using polyethylene oxide N10.
- Testing of inserts with indomethacin, ciprofloxacin hydrochloride, and prednisolone sodium phosphate.
- In vitro release, transmembrane permeability, and in vivo ocular tissue distribution studies were performed.
Main Results:
- Drug content in inserts ranged from 93% to 102%.
- Polymeric inserts enhanced transmembrane flux by 2.9- to 3.6-folds compared to controls.
- Significantly higher drug levels were observed in ocular tissues, including retina-choroid.
Conclusions:
- Melt-cast ophthalmic inserts demonstrate potential as an effective noninvasive ocular drug delivery platform.
- This technology offers benefits for treating various ocular complications.
Keywords:
anti-inflammatory drugsocular bioavailabilityocular deliveryocular insertsocular penetrationtopical polymeric insertsMore Related Videos
Related Concept Videos
Ophthalmic Drug Delivery Systems
77
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
77
Drug Delivery: Miscellaneous Routes
883
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
883
Intrauterine Drug Delivery Systems
55
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
55

